Glomerulonephritis Rapidly Progressive
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Glomerulonephritis Rapidly Progressive trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Glomerulonephritis Rapidly Progressive trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this clinical trial is to learn if a new drug that might help protect and preserve kidney function in antineutrophil cytoplasmic antibody (ANCA) ass…
The RENATO trial is a multicenter randomized controlled trial that evaluates the efficacy of pioglitazone to improve renal outcomes in ANCA-associated vasculiti…
An open-label, controlled, randomised, multi-centre Phase 3 trial evaluating renal function in patients with severe anti-GBM disease comparing imlifidase and st…
This study will evaluate the safety and tolerability of IdeS in patients with severe anti-glomerular basement membrane (anti-GBM) disease receiving standard of…